Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | 18964387627 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Thalidomide-4-NH-PEG1-NH2 TFA | C19H21F3N4O7 | 2490499-21-1 | Details |
| Thalidomide-4-NH-PEG1-NH-Boc | C22H28N4O7 | 2154342-17-1 | Details |
| JYS003 | C31H45N5O6S | 2361119-87-9 | Details |
| Ergosinine | C30H37N5O5 | 596-88-3 | Details |
| Erlizumab | 211323-03-4 | Details |
| 2,6-Diethylnaphthalene | C14H16 | 59919-41-4 | Details |
| Thalidomide-NH-(CH2)2-NH-Boc | C20H24N4O6 | 1957235-57-2 | Details |
| Roledumab | 1174008-79-7 | Details |
| Bimagrumab | 1356922-05-8 | Details |
| Vandortuzumab | 1471985-92-8 | Details |
| Dezamizumab | 1662664-56-3 | Details |
| Ieramilimab | 2137049-37-5 | Details |
| 2,3,4-Trichlorophenol acetate | C8H5Cl3O2 | 61925-89-1 | Details |
| Capromab | C10H15N5O11P2 | 145464-28-4 | Details |
| Derlotuximab | 340013-96-9 | Details |
| Clothianidin-urea | C6H8ClN3OS | 634192-72-6 | Details |
| Landogrozumab | 1391726-30-9 | Details |
| Vadastuximab | 1436390-63-4 | Details |
| Ivuxolimab | 2225940-98-5 | Details |
| Altumomab | 156586-92-4 | Details |
| 3,4,5-Trichlorophenol acetate | C8H5Cl3O2 | 59190-61-3 | Details |
| Indatuximab | 1238517-16-2 | Details |
| JYS007 | C33H49N5O8S | 2162120-75-2 | Details |
| JYS005 | C35H53N5O6S | 2306389-02-4 | Details |
| JYS006 | C31H45N5O7S | 2409007-41-4 | Details |
| Ecromeximab | 292819-64-8 | Details |
| Oportuzumab | 945228-48-8 | Details |
| Denintuzumab | 1399672-02-6 | Details |
| Olendalizumab | 1337966-73-0 | Details |
| Balstilimab | 2230167-06-1 | Details |
| Thalidomide-5-O-CH2-COO(t-Bu) | C19H20N2O7 | 2682112-10-1 | Details |
| VH032-NH-CO-CH2-NHBoc | C29H41N5O6S | 2010986-19-1 | Details |
| PBB No. 53 | C12H6Br4 | 60044-25-9 | Details |
| Narnatumab | 1188275-92-4 | Details |
| Coltuximab | 1269764-99-9 | Details |
| Ontamalimab | 2098790-40-8 | Details |
| Cibisatamab | 2101242-53-7 | Details |
| VH032-NH-CO-CH2-Br | C24H31BrN4O4S | 2379404-33-6 | Details |
| Sudan Black B Impurity 1 | C29H24N6 | 65322-64-7 | Details |
| Thalidomide-NH-(CH2)3-NH-Boc | C21H26N4O6 | 2093386-36-6 | Details |
| Thalidomide-4-NH-PEG1-COO(t-Bu) | C22H27N3O7 | 2140807-19-6 | Details |
| 6-Nitrobenz[a]pyrene | C20H11NO2 | 63041-90-7 | Details |
| Romosozumab | 909395-70-6 | Details |
| Tacatuzumab | 476413-07-7 | Details |
| Actoxumab | 1245634-25-6 | Details |
| Refanezumab | 1233953-61-1 | Details |
| Cusatuzumab | 1399546-01-0 | Details |
| Tabituximab | 1644134-10-0 | Details |
| Glucuronic Acid | C6H10O7 | 576-37-4 | Details |
| Satumomab | 144058-40-2 | Details |
| JYS002 | C26H36N4O5S | 1448189-66-9 | Details |
| JYS008 | C30H42N4O6S | 2827750-24-1 | Details |
| Ertumaxomab | 509077-99-0 | Details |
| Mapatumumab | 658052-09-6 | Details |
| Besilesomab | 537694-98-7 | Details |
| PBB No. 26 | C12H7Br3 | 59080-35-2 | Details |
| Alacizumab | 934216-54-3 | Details |
| Domagrozumab | 1629605-31-7 | Details |
| Apamistamab | 2097132-02-8 | Details |
| Sirtratumab | 1824663-82-2 | Details |
| Thalidomide-5-NH-CH2-COO(t-Bu) | C19H21N3O6 | 2412056-28-9 | Details |
| JYS001 | C23H30N4O5S | 2111829-84-4 | Details |
| PBB-No. 49 | C12H6Br4 | 60044-24-8 | Details |
| 2,2＇,5-Tribromobiphenyl | C12H7Br3 | 59080-34-1 | Details |
| Otlertuzumab | 1372645-37-8 | Details |
| Pateclizumab | 1202526-59-7 | Details |
| Evinacumab | 1446419-85-7 | Details |
| 4-Cyano-4'-undecylbiphenyl | C24H31N | 65860-74-4 | Details |
| Lintuzumab | 166089-32-3 | Details |
| Naptumomab Estafenatox | 676258-98-3 | Details |
| PCB No. 50 | C12H6Cl4 | 62796-65-0 | Details |
| Dinutuximab | 1363687-32-4 | Details |
| Radretumab | 1253180-81-2 | Details |
| Ifabotuzumab | 1234137-51-9 | Details |
| Samrotamab | 2052591-32-7 | Details |
| Tamrintamab | 2148325-59-9 | Details |
| Thalidomide-4-NH-PEG2-COO(t-Bu) | C24H31N3O8 | 2140807-16-3 | Details |
| Thalidomide-4-NH-PEG3-NH-Boc | C26H36N4O9 | 2204246-03-5 | Details |
| 4'-Cyano-4-nonyloxybiphenyl | C22H27NO | 58932-13-1 | Details |
| Tositumomab | 208921-02-2 | Details |
| Carbophenothion-methyl-sulfone | C9H12ClO4PS3 | 62059-34-1 | Details |
| 1,2-Dichlorobutane | C4H8Cl2 | 616-21-6 | Details |
| Oregovomab | 213327-37-8 | Details |
| HuCC49 | 823788-82-5 | Details |
| Perakizumab | 1331830-76-2 | Details |
| Clivatuzumab | 1462876-11-4 | Details |
| Thalidomide-4-O-CH2-COO(t-Bu) | C19H20N2O7 | 1950635-36-5 | Details |
| Testosterone-d4 | C19H28O2 | 638163-36-7 | Details |
| JYS009 | C32H46N4O6S | 2827750-25-2 | Details |
| Nacolomab Tafenatox | 150631-27-9 | Details |
| JYS004 | C33H49N5O6S | 2412055-00-4 | Details |
| caffeic acid glucoside | C15H18O9 | 892501-29-0 | Details |
| Biciromab | 138783-13-8 | Details |
| Arcitumomab | 154361-48-5 | Details |
| Zolimomab | 141483-72-9 | Details |
| Imciromab | 126132-83-0 | Details |
| Stamulumab | 705287-60-1 | Details |
| Thalidomide-NH-CH2-COO(t-Bu) | C19H21N3O6 | 2093386-23-1 | Details |
| 5,10,15,20-Tetraoxatetracosane-1,24-diol | C20H42O6 | 61136-08-1 | Details |
| Nofetumomab | 165942-79-0 | Details |
| Product Total： Product Page： | ||||
| 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||